Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 18, 2015 9:28 AM ET

Biotechnology

Company Overview of AV Therapeutics, Inc.

Company Overview

AV Therapeutics, Inc. develops cancer therapeutics and immunotherapeutic vaccines. The company identifies and patents the Capridine, a chemotherapeutic drug that has shown in preclinical models to have specific activity against prostate and colon cancer. Its cancer therapeutics and immunotherapeutic vaccines could be used together with prevalent treatment modalities, such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence. AV Therapeutics, Inc. was founded in 2011 and is headquartered in New York, New York.

20 East 68th Street

Suite 204

New York, NY 10065

United States

Founded in 2011

Phone:

917-497-5523

Key Executives for AV Therapeutics, Inc.

Chairman, Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer
Age: 66
Compensation as of Fiscal Year 2013.

AV Therapeutics, Inc. Key Developments

AV Therapeutics, Inc. Approves Auditor Change

On April 1, 2015, Marcum LLP was dismissed as the independent registered public accounting firm of AV Therapeutics, Inc. On April 1, 2015, the company engaged Accell Audit and Compliance, P.A. to serve as its independent registered public accounting firm. The decision to dismiss Marcum and engage Accell was approved by the company's board of directors.

AV Therapeutics, Inc. announced delayed annual 10-K filing

On 04/01/2015, AV Therapeutics, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

AV Therapeutics, Inc. Presents at RedChip Global Online CEO Conference, Jan-28-2015 09:30 AM

AV Therapeutics, Inc. Presents at RedChip Global Online CEO Conference, Jan-28-2015 09:30 AM.

Similar Private Companies By Industry

Company Name Region
Dance BioPharm Inc. United States
Compound Focus, Inc. United States
Parcell Laboratories, Inc. United States
Lifecore Biomedical, LLC United States
Vidus Ocular, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AV Therapeutics, Inc., please visit www.avth.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.